Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 6, 2008, Pages 1337-1343

  Elias, Peter M ^a,b   Hatano, Yutaka ^a,b   Williams, Mary L ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial peptides; atopic dermatitis; barrier function; barrier repair; cytokines; filaggrin; pH; psychologic stress; serine proteases; Staphylococcus aureus; TH2 cells

Indexed keywords

ANTIBIOTIC RESISTANCE; ATOPIC DERMATITIS; HUMAN; INFLAMMATION; INHERITANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN FUNCTION; SKIN PERMEABILITY; STRATUM CORNEUM;

DERMATITIS, ATOPIC; HUMANS; SKIN;

EID: 44649119864     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.01.022     Document Type: Review

References (89)

1. Leung D.Y. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 104 suppl (1999) S99-S108
2. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
3. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., and Hamid Q.A. New insights into atopic dermatitis. J Clin Invest 113 (2004) 651-657
4. Leung D.Y., and Soter N.A. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 44 suppl (2001) S1-S12
5. Leung D.Y. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105 (2000) 860-876
6. Elias P.M. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125 (2005) 183-200
7. Elias P.M., and Choi E.H. Interactions among stratum corneum defensive functions. Exp Dermatol 14 (2005) 719-726
8. Elias P.M. The skin barrier as an innate immune element. Semin Immunopathol 29 (2007) 3-14
9. Sugarman J.L., Fluhr J.W., Fowler A.J., Bruckner T., Diepgen T.L., and Williams M.L. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 139 (2003) 1417-1422
10. Seidenari S., and Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 75 (1995) 429-433
11. Proksch E., Folster-Holst R., and Jensen J.M. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 43 (2006) 159-169
12. Chamlin S.L., Kao J., Frieden I.J., Sheu M.Y., Fowler A.J., Fluhr J.W., et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47 (2002) 198-208
13. Eberlein-Konig B., Schafer T., Huss-Marp J., Darsow U., Mohrenschlager M., Herbert O., et al. Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol 80 (2000) 188-191
14. Boguniewicz M., and Leung D.Y. 10. Atopic dermatitis. J Allergy Clin Immunol 117 suppl (2006) S475-S480
15. Baker B.S. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 144 (2006) 1-9
16. Elias P., Wood L., and Feingold K. Relationship of the epidermal permeability barrier to irritant contact dermatitis. Immunol Allergy Clin North Am 17 (1997) 417-430
17. Elias P.M., Wood L.C., and Feingold K.R. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 10 (1999) 119-126
18. Elias P.M., and Feingold K.R. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 137 (2001) 1079-1081
19. Taieb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 41 (1999) 177-180
20. Cork M.J., Britton J., Butler L., Young S., Murphy R., and Keohane S.G. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 149 (2003) 582-589
21. Aly R., Maibach H.I., and Shinefield H.R. Microbial flora of atopic dermatitis. Arch Dermatol 113 (1977) 780-782
22. Boguniewicz M., Schmid-Grendelmeier P., and Leung D.Y. Atopic dermatitis. J Allergy Clin Immunol 118 (2006) 40-43
23. Ramirez de Knott H.M., McCormick T.S., Kalka K., Skandamis G., Ghannoum M.A., Schluchter M., et al. Cutaneous hypersensitivity to Malassezia sympodialis and dust mite in adult atopic dermatitis with a textile pattern. Contact Dermatitis 54 (2006) 92-99
24. Aberg K.M., Man M.Q., Gallo R.L., Ganz T., Crumrine D., Brown B.E., et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol (2007) [Epub ahead of print]
25. Denda M., Sato J., Tsuchiya T., Elias P.M., and Feingold K.R. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 111 (1998) 873-878
26. Elias P.M., and Menon G.K. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24 (1991) 1-26
27. Caubet C., Jonca N., Brattsand M., Guerrin M., Bernard D., Schmidt R., et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122 (2004) 1235-1244
28. Brattsand M., Stefansson K., Lundh C., Haasum Y., and Egelrud T. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 124 (2005) 198-203
29. Braff M.H., Di Nardo A., and Gallo R.L. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 124 (2005) 394-400
30. Oren A., Ganz T., Liu L., and Meerloo T. In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74 (2003) 180-182
31. Aberg K., Radek K., Choi E., Kim D., Demerjian M., Hupe M., et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 117 (2007) 3339-3349
32. Walley A.J., Chavanas S., Moffatt M.F., Esnouf R.M., Ubhi B., Lawrence R., et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 29 (2001) 175-178
33. Hachem J.P., Wagberg F., Schmuth M., Crumrine D., Lissens W., Jayakumar A., et al. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126 (2006) 1609-1621
34. Komatsu N., Takata M., Otsuki N., Ohka R., Amano O., Takehara K., et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 118 (2002) 436-443
35. Vasilopoulos Y., Cork M.J., Murphy R., Williams H.C., Robinson D.A., Duff G.W., et al. Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 123 (2004) 62-66
36. Hansson L., Backman A., Ny A., Edlund M., Ekholm E., Ekstrand Hammarstrom B., et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 118 (2002) 444-449
37. Hubiche T., Ged C., Benard A., Leaute-Labreze C., McElreavey K., de Verneuil H., et al. Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol 87 (2007) 499-505
38. Folster-Holst R., Stoll M., Koch W.A., Hampe J., Christophers E., and Schreiber S. Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany. Br J Dermatol 152 (2005) 1365-1367
39. Jongepier H., Koppelman G.H., Nolte I.M., Bruinenberg M., Bleecker E.R., Meyers D.A., et al. Polymorphisms in SPINK5 are not associated with asthma in a Dutch population. J Allergy Clin Immunol 115 (2005) 486-492
40. Hachem J.P., Crumrine D., Fluhr J., Brown B.E., Feingold K.R., and Elias P.M. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121 (2003) 345-353
41. Di Nardo A., Wertz P., Giannetti A., and Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78 (1998) 27-30
42. Imokawa G., Abe A., Jin K., Higaki Y., Kawashima M., and Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J Invest Dermatol 96 (1991) 523-526
43. Hachem J.P., Houben E., Crumrine D., Man M.Q., Schurer N., Roelandt T., et al. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 126 (2006) 2074-2086
44. Demerjian M., Hachem J.P., Tschachler E., Denecker G., Declercq W., Vandenabeele P., et al. Permeability barrier requirements regulate epidermal cornification: role of caspase 14 and the protease-activated receptor type 2. Am J Pathol 172 (2008) 86-97
45. Sator P.G., Schmidt J.B., and Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 48 (2003) 352-358
46. Irvine A.D., and McLean W.H. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 126 (2006) 1200-1202
47. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
48. Smith F.J., Irvine A.D., Terron-Kwiatkowski A., Sandilands A., Campbell L.E., Zhao Y., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38 (2006) 337-342
49. Weidinger S., Illig T., Baurecht H., Irvine A.D., Rodriguez E., Diaz-Lacava A., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118 (2006) 214-219
50. Hudson T.J. Skin barrier function and allergic risk. Nat Genet 38 (2006) 399-400
51. Segre J.A. Epidermal differentiation complex yields a secret: mutations in the cornification protein filaggrin underlie ichthyosis vulgaris. J Invest Dermatol 126 (2006) 1202-1204
52. Sandilands A., Smith F.J., Irvine A.D., and McLean W.H. Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 127 (2007) 1282-1284
53. Barker J.N., Palmer C.N., Zhao Y., Liao H., Hull P.R., Lee S.P., et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 127 (2007) 564-567
54. Stemmler S., Parwez Q., Petrasch-Parwez E., Epplen J.T., and Hoffjan S. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 127 (2007) 722-724
55. Weidinger S., Rodriguez E., Stahl C., Wagenpfeil S., Klopp N., Illig T., et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 127 (2007) 724-726
56. Presland R., Rothnagal J., and Lawrence O. Profilaggrin and the fused S100 family of calcium-binding proteins. In: Elias P.M., and Feingold K. (Eds). Skin barrier (2006), Taylor & Francis, New York 111-140
57. Scott I.R., and Harding C.R. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115 (1986) 84-92
58. Krien P., and Kermici M. Evidence for the existence of a self-regulated enzymatic process within human stratum corneum-an unexpected role for urocanic acid. J Invest Dermatol 115 (2000) 414-420
59. Hachem J.P., Fowler A., Behne M., Fluhr J., Feingold K., and Elias P. Increased stratum corneum pH promotes activation and release of primary cytokines from the stratum corneum attributable to activation of serine proteases. J Invest Dermatol 119 (2002) 258
60. Nylander-Lundqvist E., Back O., and Egelrud T. IL-1 beta activation in human epidermis. J Immunol 157 (1996) 1699-1704
61. Sandilands A., O'Regan G.M., Liao H., Zhao Y., Terron-Kwiatkowski A., Watson R.M., et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 126 (2006) 1770-1775
62. Sandilands A., Terron-Kwiatkowski A., Hull P.R., O'Regan G.M., Clayton T.H., Watson R.M., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39 (2007) 650-654
63. Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118 (2006) 3-23
64. Garg A., Chren M.M., Sands L.P., Matsui M.S., Marenus K.D., Feingold K.R., et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 137 (2001) 53-59
65. Altemus M., Rao B., Dhabhar F.S., Ding W., and Granstein R.D. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 117 (2001) 309-317
66. Denda M., Tsuchiya T., Elias P.M., and Feingold K.R. Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 278 (2000) R367-R372
67. Choi E.H., Demerjian M., Crumrine D., Brown B.E., Mauro T., Elias P.M., et al. Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1657-R1662
68. Choi E.H., Brown B.E., Crumrine D., Chang S., Man M.Q., Elias P.M., et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 124 (2005) 587-595
69. Kurahashi R., Hatano Y., and Katagiri C. IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J Invest Dermatol (2007) Oct 25 [epub ahead of print]
70. Hatano Y., Terashi H., Arakawa S., and Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol 124 (2005) 786-792
71. Howell M.D., Kim B.E., Gao P., Grant A.V., Boguniewicz M., Debenedetto A., et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120 (2007) 150-155
72. Kobayashi J., Inai T., Morita K., Moroi Y., Urabe K., Shibata Y., et al. Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-gamma and IL-4. Cytokine 28 (2004) 186-189
73. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
74. Miller S.J., Aly R., Shinefeld H.R., and Elias P.M. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 124 (1988) 209-215
75. Fluhr J.W., and Elias P.M. Stratum corneum pH: formation and function of the "acid mantle. Exog Dermatol 1 (2002) 163-175
76. Bibel D.J., Aly R., and Shinefield H.R. Antimicrobial activity of sphingosines. J Invest Dermatol 98 (1992) 269-273
77. Clarke S.R., Mohamed R., Bian L., Routh A.F., Kokai-Kun J.F., Mond J.J., et al. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1 (2007) 199-212
78. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171 (2003) 3262-3269
79. Zaiou M., Nizet V., and Gallo R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120 (2003) 810-816
80. Komatsuzawa H., Ouhara K., Yamada S., Fujiwara T., Sayama K., Hashimoto K., et al. Innate defences against methicillin-resistant Staphylococcus aureus (MRSA) infection. J Pathol 208 (2006) 249-260
81. Kisich K.O., Howell M.D., Boguniewicz M., Heizer H.R., Watson N.U., and Leung D.Y. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127 (2007) 2368-2380
82. Lomholt H., Andersen K.E., and Kilian M. Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J Invest Dermatol 125 (2005) 977-982
83. Wehner J., and Neuber K. Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. Br J Dermatol 145 (2001) 302-305
84. Lehmann H.S., Heaton T., Mallon D., and Holt P.G. Staphylococcal enterotoxin-B-mediated stimulation of interleukin-13 production as a potential aetiologic factor in eczema in infants. Int Arch Allergy Immunol 135 (2004) 306-312
85. Langer K., Breuer K., Kapp A., and Werfel T. Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis. Exp Dermatol 16 (2007) 124-129
86. Leung D.Y., Harbeck R., Bina P., Reiser R.F., Yang E., Norris D.A., et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92 (1993) 1374-1380
87. Gould H.J., Takhar P., Harries H.E., Chevretton E., and Sutton B.J. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Chem Immunol Allergy 93 (2007) 106-136
88. Sonkoly E., Muller A., Lauerma A.I., Pivarcsi A., Soto H., Kemeny L., et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117 (2006) 411-417
89. Sugarman J., and Parish L.J. A topical lipid-based barrier repair formulation (EpiCeram™ cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis. J Invest Dermatol (2008) In press